HilleVax
Stock Forecast, Prediction & Price Target
HilleVax Financial Estimates
HilleVax Revenue Estimates
HilleVax EBITDA Estimates
HilleVax Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $2.5M Low: $2.5M High: $2.5M avg. 0% | Avg: $118.33M Low: $118.33M High: $118.33M avg. 4633.45% | Avg: $286.13M Low: $286.13M High: $286.13M avg. 141.79% |
Net Income
% change YoY
| $-85.02M N/A | $-257.00M -202.26% | $-123.56M 51.92% | Avg: $-183.83M Low: $-162.79M High: $-107.99M avg. -48.77% | Avg: $-226.64M Low: $-175.38M High: $-113.26M avg. -23.29% | Avg: $-96.21M Low: $-96.21M High: $-96.21M avg. 57.54% | Avg: $-29.63M Low: $-29.63M High: $-29.63M avg. 69.19% |
EBITDA
% change YoY
| $-35.99M N/A | $-60.11M -67.00% | $-132.46M -120.36% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$2.82 N/A | -$6.83 -142.19% | -$3.04 55.49% | Avg: -$3.21 Low: -$4.01 High: -$2.66 avg. -5.59% | Avg: -$3.6 Low: -$4.32 High: -$2.79 avg. -12.02% | Avg: -$2.37 Low: -$2.37 High: -$2.37 avg. 34.09% | Avg: -$0.73 Low: -$0.73 High: -$0.73 avg. 69.19% |
Operating Expenses
% change YoY
| $15.77M N/A | $62.61M 297.03% | $133.34M 112.96% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is HilleVax stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 13.67% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -162.79M, average is -183.83M and high is -107.99M.
What is HilleVax stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1193.81% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is HilleVax stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 21.41% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$4.01, average is -$3.21 and high is $-2.66.
What is the best performing analyst?
In the last twelve months analysts have been covering HilleVax stock. The most successful analyst is Stephen Willey.